Professional Documents
Culture Documents
Credentials:
Education:
1971 – 1975 BS – Biology/Psychology, University of Washington, Seattle,
Washington
1975 – 1979 MD – University of Washington, Seattle, Washington
1979 – 1980 Internship: San Diego Veterans Administration Hospital – Surgery, La
Jolla, California
1979 – 1980 Internship: University Hospital, San Diego, California
1980 – 1981 Residency: City of Hope Hospital, Durante, California
1980 – 1981 Surgical Residency: San Diego Veterans Administration Hospital, La Jolla,
California
1980 – 1981 Residency: University Hospital, San Diego, California
1981 – 1985 Urology, Baylor College of Medicine Affiliated Hospitals, Houston,
Texas
Endourology and Extracorporeal Shock Wave Lithotripsy
Genitourinary Prosthetics
Microvascular Surgery (80 hour instructional course)
Work Experience:
2005 - Present Medical Director Seattle Urology Research Center
1991 – Present Clinical Research: Principal and Sub Investigator
1988 – Present Physician – Private Practice Urology; 16259 Sylvester Road
Southwest, Suite 303, Seattle, Washington
1985 – 1987 Private Urology Practice – Kent Medical Center, Kent, Washington
Hospital Affiliations:
September 2007 1
Curriculum Vitae For:
Jeffrey Marc Frankel, MD
Board of Director Affiliations:
Professional Affiliations
Active Member, Washington State Urological Society
Active Member, Northwest Urological Association
Active Member, King County Medical Society
Active Member, American Urological Association, Western Section
Active Member, American Urological Association
Active Member, American Association of Clinical Urologists
Research Activities:
September 2007 2
Curriculum Vitae For:
Jeffrey Marc Frankel, MD
4. A Double-Blind, Randomized, Parallel Group Trial of XXXXX® Extended
Release Tablets or Placebo In Combination with XXXXX® For the Treatment Of
Lower Urinary Tract Symptoms (Protocol CAPSS-292)
14. A Phase II Study Evaluating The Safety And Efficacy Of XXXXX In Men With
Hormone Naïve Prostate Cancer That Are Exhibiting Early Signs Of Biochemical
Failure.
17. A Phase III Extension Study To Evaluate The Safety Of XXXXX mg XXXXX In
Men With Hormone-Refractory Prostate Cancer.
33. A Multi-Center Open Label Evaluation of the Safety of xxxxxxxxx in the Treatment of
the Symptoms of Benign Prostatic Hyperplasia.
37. A Multicenter , Double-Blind, Placebo controlled, Flexible- Dose Study with an Open
Label Phase to asses the Efficacy of xxxxxxxxxxx xxxxxxx On Erectile Function and
intercourse satisfaction as well as to Validate the Sexual experience Questionnaire and its
Treatment Responsiveness in man with Erectile Dysfunction.
39. A Phase 3 Extension Study to Evaluate the Safety of xxxxxxxxxxxx, in Man with
Hormone-Refractory Prostate Cancer.
September 2007 5
Curriculum Vitae For:
Jeffrey Marc Frankel, MD
Publications:
September 2007 6